The arteriographic findings in two cases of hemangiosarcoma of the spleen with liver metastases are described. These are the second and third reported cases of angiographically demonstrated malignant splenic tumors of vascular origin. Despite the absence of tumor vessels, there were multiple vascular takes in the arterial through the venous phase, mimicking benign cavernous hemangioma. Multiple metastases in the liver were the only clue to malignancy. Arteriography combined with liver-spleen scintigraphy not only provides information which is valuable in the preoperative diagnosis but also aids in management of the patient.

Download full-text PDF

Source
http://dx.doi.org/10.1148/123.1.31DOI Listing

Publication Analysis

Top Keywords

hemangiosarcoma spleen
8
spleen liver
8
liver metastases
8
metastases angiographic
4
angiographic manifestations
4
manifestations arteriographic
4
arteriographic findings
4
findings cases
4
cases hemangiosarcoma
4
metastases described
4

Similar Publications

The objectives of this study were to evaluate the risk and predictive factors of splenic malignancy and hemangiosarcoma in dogs undergoing splenectomy at a surgical specialty clinic. Medical records, hematologic results, surgical reports, and histopathologic results from 182 dogs that underwent splenectomy for the treatment of splenic masses or nodules were reviewed retrospectively. The majority of dogs (57.

View Article and Find Full Text PDF

Primary Liposarcoma of the Spleen: Case Report With Review of the Literature.

Int J Surg Pathol

November 2024

Department of General and Visceral Surgery, Klinikum Fulda, Fulda, Germany.

We present a 55-year-old woman with a palpable mass in the right upper abdomen. Contrast-enhanced computed tomography showed a highly vascularized and primary resectable tumor of the spleen. We performed an open splenectomy with locoregional lymphadenectomy.

View Article and Find Full Text PDF

Ultrasonographic characteristics of splenic stromal sarcoma in 13 dogs.

Vet Radiol Ultrasound

January 2025

Department of Diagnostic Imaging, Friendship Hospital for Animals, Washington, District of Columbia, USA.

Article Synopsis
  • The study explores the challenges of diagnosing solitary splenic masses in dogs using abdominal ultrasound, which often can't definitively distinguish between benign and malignant lesions.
  • Common differential diagnoses include various conditions such as hemangiosarcoma and hematoma, but less frequent tumors like splenic stromal sarcoma are also considered.
  • The research specifically evaluated 13 dogs with splenic stromal sarcoma, noting that the masses were solid, noncavitary, and located in the mid-body of the spleen, suggesting that ultrasound can be a helpful diagnostic tool in these cases.
View Article and Find Full Text PDF

Background: Angiosarcomas are highly aggressive malignancies with endothelial differentiation, presenting considerable challenges in oncology, especially when arising in rare locations such as the spleen. These tumors predominantly affect adults and are commonly found in the skin, breast, liver, or soft tissues, with more unusual occurrences in other organs. Angiosarcomas have a high propensity for metastasis, typically spreading to the liver, lungs, lymph nodes, and gastrointestinal tract.

View Article and Find Full Text PDF

Background: Angiosarcomas are rare tumors that can be difficult to diagnose due to subtle changes in the vascular endothelium. When there is evidence to suggest malignancy, such as a pathologic fracture, further investigation is needed, and a high suspicion for angiosarcoma needs to be present so that appropriate immunohistochemical stains are utilized on biopsied tissue. In situations where such suspicion is high and prior biopsies have been negative, performance of splenectomy, can be both diagnostic and therapeutic when splenomegaly is present.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!